Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Metuzals, J.
Robitaille, Y.
Houghton, S.
Gauthier, S.
and
Leblanc, R.
1987.
Alterations in the Neuronal Cytoskeleton in Alzheimer Disease.
Vol. 34,
Issue. ,
p.
75.
McRae-Degueurce, Amanda
Hjorth, Stephan
Dillon, D.Lynn
Mason, David W.
and
Tice, Thomas R.
1988.
Implantable microencapsulated dopamine (DA): A new approach for slow-release DA delivery into brain tissue.
Neuroscience Letters,
Vol. 92,
Issue. 3,
p.
303.
Spinnler, H.
and
Sala, S. Della
1988.
The role of clinical neuropsychology in the neurological diagnosis of Alzheimer's disease.
Journal of Neurology,
Vol. 235,
Issue. 5,
p.
258.
Metuzals, Jams
Robitaille, Yves
Houghton, Susan
Gauthier, Serge
and
Leblanc, Richard
1988.
Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer's disease.
Journal of Neurocytology,
Vol. 17,
Issue. 6,
p.
827.
Vida, Stephen
Gauthier, Louise
and
Gauthier, Serge
1989.
Canadian Collaborative Study of Tetrahydroaminoacridine (THA) and Lecithin Treatment of Alzheimer's Disease: Effect on Mood.
The Canadian Journal of Psychiatry,
Vol. 34,
Issue. 3,
p.
165.
Hallak, M.
and
Giacobini, E.
1989.
Physostigmine, tacrine and metrifonate: The effect of multiple doses on acetylcholine metabolism in rat brain.
Neuropharmacology,
Vol. 28,
Issue. 3,
p.
199.
Harbaugh, Robert E.
1989.
Novel CNS-directed drug delivery systems in Alzheimer's disease and other neurological disorders.
Neurobiology of Aging,
Vol. 10,
Issue. 5,
p.
623.
Read, Stephen
1989.
Methodological considerations in cognitive disorders or: “The baby needs enough bath water”.
Neurobiology of Aging,
Vol. 10,
Issue. 5,
p.
634.
McRae, Amanda
Hjorth, S.
Mason, D.
Dillon, L.
and
Tice, T.
1990.
Neurotransmitter Actions and Interactions.
p.
207.
Gauthier, S.
Gauthier, L.
Bouchard, R.
Quirion, R.
and
Sultan, S.
1991.
Treatment of Alzheimer's Disease: Hopes and Reality.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 18,
Issue. S3,
p.
439.
Mozell, Everett J.
Woltering, Eugene A.
and
O'Dorisio, Thomas M.
1991.
Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy.
Disease-a-Month,
Vol. 37,
Issue. 12,
p.
749.
Schwarz, R.D.
Callahan, M.J.
Davis, R.E.
Jaen, J.C.
and
Tecle, H.
1997.
Development of M1 subtype selective muscarinic agonists for Alzheimer's disease: Translation of in vitro selectivity into in vivo efficacy.
Drug Development Research,
Vol. 40,
Issue. 2,
p.
133.
Sramek, John J
Forrest, Misser
Mengel, Helle
Jhee, Stanford S
Hourani, Jameel
and
Cutler, Neal R
1997.
A BRIDGING STUDY OF LU 25-109 IN PATIENTS WITH PROBABLE ALZHEIMER'S DISEASE.
Life Sciences,
Vol. 62,
Issue. 3,
p.
195.
Gupta, Ramesh C.
and
Dekundy, A.
2005.
Memantine does not influence AChE inhibition in rat brain by donepezil or rivastigmine but does with DFP and metrifonate in in vivo studies.
Drug Development Research,
Vol. 64,
Issue. 1,
p.
71.
Naseri Kouzehgarani, Ghazal
Feldsien, Thomas
Engelhard, Herbert H.
Mirakhur, Kuldip K.
Phipps, Colin
Nimmrich, Volker
Clausznitzer, Diana
and
Lefebvre, Didier R.
2021.
Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues.
Advanced Drug Delivery Reviews,
Vol. 173,
Issue. ,
p.
20.